Skip to main content

Advertisement

Log in

A Multicenter Cohort Study of Immune Dysregulation Disorders Caused by ELF4 Variants in China

  • Original Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Patients with DEX (deficiency in ELF4, X-linked) were recently reported by our team and others, and cases are very limited worldwide. Our knowledge of this new disease is currently preliminary. In this study, we described 5 more cases presenting mainly with oral ulcer, inflammatory bowel disease-like symptoms, fever of unknown origin, anemia, or systemic lupus erythematosus. Whole exome sequencing identified potential pathogenic ELF4 variants in all cases. The pathogenicity of these variants was confirmed by the detection of ELF4 expression in peripheral blood mononuclear cells from patients and utilizing a simple IFN-b luciferase reporter assay, as previously reported. Our findings significantly contribute to the current understanding of DEX.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The data that support the findings of this study are available from the corresponding authors upon reasonable request.

Code Availability

Not applicable.

Abbreviations

IEIs:

Inborn errors of immunity

ETS:

The E-twenty-six domain

DEX:

Deficiency in ELF4, X-linked

SLE:

Systemic lupus erythematosus

IVIG:

Intravenous immunoglobulin therapy

NSAIDs:

Nonsteroidal anti-inflammatory drugs

PBMCs:

Peripheral blood mononuclear cells

CADD:

Combined annotation dependent depletion

CMBI:

Centre for molecular and biomolecular informatics

MMP-9:

Matrix metalloproteinase-9

References

  1. Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42(7):1473–507. https://doi.org/10.1007/s10875-022-01289-3.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sun G, Qiu L, Yu L, An Y, Ding Y, Zhou L, et al. Loss of function mutation in ELF4 causes autoinflammatory and immunodeficiency disease in human. J Clin Immunol. 2022;42:798–810. https://doi.org/10.1007/s10875-022-01243-3.

    Article  CAS  PubMed  Google Scholar 

  3. Tyler PM, Bucklin ML, Zhao M, Maher TJ, Rice AJ, Ji W, et al. Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation. Nat Immunol. 2021;22:1118–26. https://doi.org/10.1038/s41590-021-00984-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Salinas SA, Mace EM, Conte MI, Park CS, Li Y, Rosario-Sepulveda JI, et al. An ELF4 hypomorphic variant results in NK cell deficiency. JCI Insight. 2022;7(23):e155481. https://doi.org/10.1172/jci.insight.155481.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hollenhorst PC, McIntosh LP, Graves BJ. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem. 2011;80:437–71. https://doi.org/10.1146/annurev.biochem.79.081507.103945.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lacorazza HD, Miyazaki Y, di Cristofano A, Deblasio A, Hedvat C, Zhang J, et al. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity. 2002;17:437–49. https://doi.org/10.1016/S1074-7613(02)00422-3.

    Article  CAS  PubMed  Google Scholar 

  7. Choi H-J, Geng Y, Cho H, Li S, Giri PK, Felio K, et al. Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells. Blood. 2011;117:1880–7. https://doi.org/10.1182/blood-2010-09-309468.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. You F, Wang P, Yang L, Yang G, Zhao YO, Qian F, et al. ELF4 is critical for induction of type i interferon and the host antiviral response. Nat Immunol. 2013;14:1237–46. https://doi.org/10.1038/ni.2756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Yamada T, Park CS, Mamonkin M, Lacorazza HD. Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2. Nat Immunol. 2009;10:618–26. https://doi.org/10.1038/ni.1730.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mamonkin M, Puppi M, Lacorazza HD. Transcription factor ELF4 promotes development and function of memory CD8+ T cells in Listeria monocytogenes infection. Eur J Immunol. 2014;44:715–27. https://doi.org/10.1002/eji.201343775.

    Article  CAS  PubMed  Google Scholar 

  11. Lv G, Sun G, Wu P, du X, Zeng T, Wen W, et al. Novel mutations of TYK2 leading to divergent clinical phenotypes. Pediatr Allergy Immunol. 2022;33(1):e13671. https://doi.org/10.1111/pai.13671.

    Article  CAS  PubMed  Google Scholar 

  12. Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47:D886–94. https://doi.org/10.1093/nar/gky1016.

    Article  CAS  PubMed  Google Scholar 

  13. Stewart DM, Tian L, Notarangelo LD, Nelson DL. X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update. Immunol Res. 2008;40:262–70. https://doi.org/10.1007/s12026-007-0028-9.

    Article  CAS  PubMed  Google Scholar 

  14. Ding Y, Zhou L, Xia Y, Wang W, Wang Y, Li L, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J Allergy Clin Immunol. 2018;142:970–973.e8. https://doi.org/10.1016/j.jaci.2018.04.022.

    Article  PubMed  Google Scholar 

  15. Suico MA, Shuto T, Kai H. Roles and regulations of the ETS transcription factor ELF4/MEF. J Mol Cell Biol. 2017;9:168–77. https://doi.org/10.1093/jmcb/mjw051.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Szabo A, Rajnavolgyi E. Finding a fairy in the forest: ELF4, a novel and critical element of type I interferon responses. Cell Mol Immunol. 2014;11:218–20. https://doi.org/10.1038/cmi.2014.1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hedvat CV, Yao JJ, Sokolic RA, Nimer SD. Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J Biol Chem. 2004;279:6395–400. https://doi.org/10.1074/jbc.M307524200.

    Article  CAS  PubMed  Google Scholar 

  18. Seki Y, Suico MA, Uto A, Hisatsune A, Shuto T, Isohama Y, et al. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome. Cancer Res. 2002;62(22):6579–86.

    CAS  PubMed  Google Scholar 

  19. Mitchell GB, Albright BN, Caswell JL. Effect of interleukin-8 and granulocyte colony-stimulating factor on priming and activation of bovine neutrophils. Infect Immun. 2003;71:1643–9. https://doi.org/10.1128/IAI.71.4.1643-1649.2003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Gilet A, Zou F, Boumenir M, Frippiat JP, Thornton SN, Lacolley P, et al. Aldosterone up-regulates MMP-9 and MMP-9/NGAL expression in human neutrophils through p38, ERK1/2 and PI3K pathways. Exp Cell Res. 2015;331:152–63. https://doi.org/10.1016/j.yexcr.2014.11.004.

    Article  CAS  PubMed  Google Scholar 

  21. Suico MA, Yoshida H, Seki Y, Uchikawa T, Lu Z, Shuto T, et al. Myeloid Elf-1-like factor, an ETS transcription factor, up-regulates lysozyme transcription in epithelial cells through interaction with promyelocytic leukemia protein. J Biol Chem. 2004;279:19091–8. https://doi.org/10.1074/jbc.M312439200.

    Article  CAS  PubMed  Google Scholar 

  22. Curina A, Termanini A, Barozzi I, Prosperini E, Simonatto M, Polletti S, et al. High constitutive activity of a broad panel of housekeeping and tissue-specific cis-regulatory elements depends on a subset of ETS proteins. Genes Dev. 2017;31:399–412. https://doi.org/10.1101/gad.293134.116.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the patients and their families for their cooperation. We thank the members of our laboratory for their technical assistance.

Funding

This study is funded by the National Natural Science Foundation of China (82101908), Postdoc Fund of Chongqing Natural Science Foundation (cstc2021jcyj-bshX0226), General Basic Research Project from the Ministry of Education Key Laboratory of Child Development and Disorders (GBRP-202110), CQMU Program for Youth Innovation in Future Medicine (W0100), Sanming Project of Medicine in Shenzhen (SZSM201812002), Livelihood Project of Chongqing, China (cstc2018jscxmsybX0005).

Author information

Authors and Affiliations

Authors

Contributions

HQ.D, XD.Z, YM.X, L.S, ZX.W, and XR.Z conceived and supervised the project, reviewed, and revised the manuscript; G.S performed the experiments, analyzed data, and wrote the manuscript; ML.W and QY.L followed the patients and collected clinical data. Others provided essential help for clinical management, follow-up of the patient, and valuable clinical expertise in reviewing the manuscript.

Corresponding authors

Correspondence to Xiangrong Zheng, Zhaoxia Wang, Li Sun, Yongmei Xie, Xiaodong Zhao or Hongqiang Du.

Ethics declarations

Ethics Approval

The ethics committee of Children’s Hospital of Chongqing Medical University, Children’s Hospital of Fudan University, Xiangya Hospital Central South University, West China Second University Hospital and Shenzhen Children’s Hospital approved the study. Blood sample collections were performed in accordance with the Declaration of Helsinki.

Consent to Participate

Written informed consent for participation in the study was obtained from patients’ parents.

Consent for Publication

Written informed consent for publication of the study was obtained from patients’ parents.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, G., Wu, M., Lv, Q. et al. A Multicenter Cohort Study of Immune Dysregulation Disorders Caused by ELF4 Variants in China. J Clin Immunol 43, 933–939 (2023). https://doi.org/10.1007/s10875-023-01453-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-023-01453-3

Keywords

Navigation